Cargando…
Genome-wide screening and immune landscape suggest a potential-m6A-related lncRNA risk signature for predicting prognosis of melanoma
BACKGROUND: Melanoma is the most dangerous form of skin cancer because of its high metastatic potential. Potential-N6-methyladenosine (m6A)-related long noncoding RNAs (pMRlncRNAs) play a vital role in malignancy. The identification of prognostic-related pMRlncRNAs and development of risk signatures...
Autores principales: | Shen, Kangjie, Wang, Hongye, Xue, Shengbai, Wang, Lu, Ren, Ming, Gao, Zixu, Wei, Chuanyuan, Gu, Jianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987876/ https://www.ncbi.nlm.nih.gov/pubmed/35402579 http://dx.doi.org/10.21037/atm-21-4402 |
Ejemplares similares
-
Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts
por: Gao, Zixu, et al.
Publicado: (2022) -
Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
por: Shen, Kangjie, et al.
Publicado: (2023) -
Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients
por: Li, Zhehong, et al.
Publicado: (2022) -
Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021) -
TRIP13/FLNA Complex Promotes Tumor Progression and Is Associated with Unfavorable Outcomes in Melanoma
por: Lu, Wang, et al.
Publicado: (2022)